Mosaic Family Wealth Partners »

Novo Nordisk A/S shares owned by Mosaic Family Wealth Partners

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Mosaic Family Wealth Partners from 13F filings

Historical chart of Mosaic Family Wealth Partners investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Mosaic Family Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Mosaic Family Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $276k 1.9k 142.74
2024-03-31 $226k 1.8k 128.40

More positions owned by Mosaic Family Wealth Partners

Vanguard Growth Etf Growth Etf (VUG)
Dimensional Us Large Cap Value Etf Us Large Cap Val (DFLV)
Xtrackers Msci Eafe Hedged Equity Etf Xtrack Msci Eafe (DBEF)
Vanguard Value Etf Value Etf (VTV)
Vanguard Small-cap Growth Etf Sml Cp Grw Etf (VBK)
Dimensional Emerging Markets Core Equity 2 Etf Emerging Mkts Co (DFEM)
Dimensional Us Small Cap Value Etf Us Small Cap Val (DFSV)
Dimensional U.s. Targeted Value Etf Us Targeted Vlu (DFAT)
Apple (AAPL)
Vanguard Ftse Developed Markets Etf Ftse Dev Mkt Etf (VEA)
Dimensional Global Real Estate Etf Global Real Est (DFGR)
Dimensional International Core Equity 2 Etf Intl Core Equity (DFIC)
Dimensional Us Marketwide Value Etf Us Mktwide Value (DFUV)
Vanguard Total Bond Market Etf Total Bnd Mrkt (BND)
Microsoft Corporation (MSFT)

View all positions for Mosaic Family Wealth Partners

Top funds holding Novo Nordisk A/S

Jennison Associates
Morgan Stanley
Bank of America Corporation
Fisher Investments
Fayez Sarofim & Co
T. Rowe Price Associates
Folketrygdfondet
Renaissance Technologies
GQG Partners
Capital Research and Management Company - Division 3
Polen Capital Management
Everett Harris & Co
State Street Corporation
State Farm Mutual Automobile Insurance Company
BlackRock

View all funds holding Novo Nordisk A/S